share_log

Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics

Benzinga ·  Jul 31 23:01

Throughout the last three months, 13 analysts have evaluated Nurix Therapeutics (NASDAQ:NRIX), offering a diverse set of opinions from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings67000
Last 30D10000
1M Ago13000
2M Ago23000
3M Ago21000

Insights from analysts' 12-month price targets are revealed, presenting an average target of $29.54, a high estimate of $36.00, and a low estimate of $20.00. This current average reflects an increase of 6.64% from the previous average price target of $27.70.

1722438090_0.png

Deciphering Analyst Ratings: An In-Depth Analysis

The standing of Nurix Therapeutics among financial experts becomes clear with a thorough...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment